Antiplatelet Therapy in Patients Undergoing CABG for Acute Coronary Syndrome: Indications, Benefits, and Strategies to Reduce Perioperative Bleeding– Outline available guidelines for acute coronary syndrome (ACS) management, which incorporate newer antiplatelet agents and evidence. Describe the benefits and limitations of available antiplatelet therapies, including risk of major bleeding, genetic factors, and reversibility. Evaluate the role of platelet reactivity testing and point-of-care genetic testing. Adhere to guideline-directed and evidence-based pre-, peri-, and post-procedural antiplatelet strategies in patients with ACS.
1.5 Free CEUs for Radiologic Technologists
This course also offers Free CME for Physicians
Supported by an independent educational grant from AstraZeneca